BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 545.01B
Enterprise Value 346.92B
Trailing P/E 10.60
Forward P/E 17.66
PEG Ratio (5 yr expected) 12.00
Price/Sales (ttm)3.35
Price/Book (mrq)3.46
Enterprise Value/Revenue 33.49
Enterprise Value/EBITDA 66.68

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 32.94%
Operating Margin (ttm)47.39%

Management Effectiveness

Return on Assets (ttm)16.28%
Return on Equity (ttm)34.91%

Income Statement

Revenue (ttm)13.45B
Revenue Per Share (ttm)65.66
Quarterly Revenue Growth (yoy)6.60%
Gross Profit (ttm)11.64B
EBITDA 7.03B
Net Income Avi to Common (ttm)4.43B
Diluted EPS (ttm)21.58
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.54B
Total Cash Per Share (mrq)17.99
Total Debt (mrq)5.94B
Total Debt/Equity (mrq)45.56
Current Ratio (mrq)2.32
Book Value Per Share (mrq)66.12

Cash Flow Statement

Operating Cash Flow (ttm)6.19B
Levered Free Cash Flow (ttm)3.81B

Trading Information

Stock Price History

Beta (3Y Monthly) 1.85
52-Week Change 3-13.64%
S&P500 52-Week Change 310.27%
52 Week High 3388.67
52 Week Low 3216.12
50-Day Moving Average 3264.59
200-Day Moving Average 3307.03

Share Statistics

Avg Vol (3 month) 32.27M
Avg Vol (10 day) 32.25M
Shares Outstanding 5196.71M
Float 196.39M
% Held by Insiders 10.47%
% Held by Institutions 193.42%
Shares Short (Mar 29, 2019) 43.56M
Short Ratio (Mar 29, 2019) 41.11
Short % of Float (Mar 29, 2019) 41.69%
Short % of Shares Outstanding (Mar 29, 2019) 41.81%
Shares Short (prior month Feb 28, 2019) 42.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Jan 18, 2001